Clinical Trial Update: A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

View source ↗

Summary

Clinical trial update describing a screening study to identify BRAF V600 mutation–positive patients for enrollment into Zelboraf (vemurafenib) studies; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Neoplasms

Drugs mentioned

• Zelboraf (vemurafenib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Multiple Myeloma, Neoplasms | Status: COMPLETED | Results posted: 2015-07-31